Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA4503 in Major Depressive Disorder
NCT00551109Phase 2Completed
- Sponsor
- M's Science Corporation
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cutamesine in major depressive disorder (MDD), sponsored by M's Science Corporation. Started Nov 2007; status: completed.
02
Drugs
cutamesine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00551109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551109.